D. Gary Gilliland
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, Eosinophilic Disorders and Syndromes, Cytokine Signaling Pathways and Interactions
Most-Cited Works
- → Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1(2009)4,112 cited
- → Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis(2005)2,971 cited
- → A Tyrosine Kinase Created by Fusion of the PDGFRA and FIP1L1 Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome(2003)1,690 cited
- → FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress(2007)1,536 cited
- → The roles of FLT3 in hematopoiesis and leukemia(2002)1,535 cited
- → MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia(2006)1,402 cited
- → JAK2 Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis(2007)1,237 cited
- → FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell Homeostasis(2007)1,026 cited
- → Activating mutations in ALK provide a therapeutic target in neuroblastoma(2008)888 cited
- → Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel(2007)857 cited